Abstract released by ASH today, earlier than expected
Updated results from study combining bemcentinib with LDAC in AML
Initial results show promise in newly diagnosed and relapsed patients
Full dataset will be presented December 6th at the ASH conference
04 Nov 2020
Updated results in AML study
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Updated results in AML study
Abstract released by ASH today, earlier than expected
Updated results from study combining bemcentinib with LDAC in AML
Initial results show promise in newly diagnosed and relapsed patients
Full dataset will be presented December 6th at the ASH conference